Tightly clustered outbreak of group A streptococcal disease at a long-term care facility

Infection Control and Hospital Epidemiology

Volumn 27, Issue 12, 2006, Pages 1377-1384

  Arnold, Kathryn E ^a,c   Schweitzer, Jody L ^a,b   Wallace, Barbara ^a   Salter, Monique ^a   Neeman, Ruth ^a   Hlady, W Gary ^a   Beall, Bernard ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NEW HAMPSHIRE DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^c Division of Public Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZATHINE PENICILLIN; RIFAMPICIN;

ARTICLE; BLOOD CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; HEALTH CARE FACILITY; HEALTH SURVEY; HOSPITAL BED; HOSPITALIZATION; HUMAN; INFECTION CONTROL; LONG TERM CARE; MORTALITY; PATHOGENESIS; QUESTIONNAIRE; SELF REPORT; STOMACH TUBE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION;

AGED; CARRIER STATE; CROSS-SECTIONAL STUDIES; DISEASE OUTBREAKS; HANDWASHING; HUMANS; INFECTION CONTROL; LONG-TERM CARE; NURSING HOMES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 33845980244     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/508820     Document Type: Article

References (27)

1. Richards C. Infections in residents of long-term care facilities; an agenda for research, report of an expert panel. J Am Geriatr Soc 2002; 50:570-576.
2. Strausbaugh LJ, Sukumar SR, Joseph CL. Infectious disease outbreaks in nursing homes: an unappreciated hazard for frail elderly persons. Clin Infect Dis 2003; 36:870-876.
3. Thigpen MC, Greene CM, Kupronis BA, et al. Incidence and characteristics of invasive group A streptococcal infection among residents of long-term care facilities-1998-2003. Presented at: 42nd Annual Meeting of the Infectious Diseases Society of America; September 30 to October 3, 2004; Boston, MA. Abstract 290.
4. Greene CG, Van Beneden C, Javadi M, et al. Cluster of deaths from group A streptococcus in a long-term care facility-Georgia 2001. Am J Infect Control 2005; 33:108-113.
5. Schwartz B, Ussery X. Group A streptococcal outbreaks in nursing homes. Infect Control Hosp Epidemiol 1992; 13:742-747.
6. Schwartz B, Elliott JA, Butler JC, et al. Clusters of invasive group A streptococcal infections in family, hospital, and nursing home settings. Clin Infect Dis 1992; 15:277-284.
7. Centers for Disease Control and Prevention. Nursing home outbreaks of invasive group A streptococcal infections-Illinois, Kansas, North Carolina, and Texas. MMWR Morb Mortal Wkly Rep 1990; 39:577-579.
8. Auerbach SB, Schwartz B, Williams D, et al. Outbreak of invasive group A streptococcal infections in a nursing home. Arch Intern Med 1992; 152:1017-1022.
9. The Prevention of Invasive Group A Streptococcal Infections Workshop Participants. Prevention of invasive group A streptococcal disease among household contacts of case patients and among postpartum and post-surgical patients: recommendations from the Centers for Disease Control and Prevention. Clin Infect Dis 2002; 35:950-959.
10. O'Brien K, Beall B, Barrett NL, et al. Epidemiology of invasive group A Streptococcus disease in the United States, 1995-1999. Clin Infect Dis 2002; 35:268-276.
11. Rasma HA, Norrby-Teglund Y, Gueder A, et al. Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity. Infect Immun 1999; 67:1871-1877.
12. Kotb M, Norrby-Teglund A, McGeer A, et al. An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat Med 2002; 8:1398-1404.
13. Sharkawy A, Low DE, Saginur R, et al. Severe group A streptococcal soft-tissue infections in Ontario 1992-1996. The Ontario Group A Streptococcal Study Group. Clin Infect Dis 2002; 34:454-460.
14. Li Z, Sakota V, Jackson D, Franklin AR, Beall B. The array of M protein gene subtypes in 1061 recent invasive group A streptococcal isolates recovered from the Active Bacterial Core Surveillance. J Infect Dis 2003; 188:1587-1592.
15. Shulman ST, Tanz RR, Kabat W, et al. Group A streptococcal pharyngitis serotype surveillance in North America, 2000-2002. Clin Infect Dis 2004; 39:325-332.
16. Kline JB, Collins CM. Analysis of the superantigenic activity of mutant and allelic forms of streptococcal pyrogenic exotoxin A. Infect Immun 1996; 64:861-869.
17. Musser JM, Kapur V, Kanjilal S, et al. Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (scarlet fever toxin). J Infect Dis 1993; 167:337-346.
18. Beres SB, Sylva GL, Barbian KD, et al. Genome sequence of a serotype M3 strain of group A streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence. Proc Natl Natl Sci U S A 2002; 99:10078-10083.
19. Reda KB, Kapur V, Mollick JA, Lamphear JG, Musser JM, Rich RR. Molecular characterization and phylogenetic distribution of the streptococcal superantigen gene (ssa) from Streptococcus pyogenes. Infect Immun 1994; 62:1867-1874.
20. Eyal O, Jadoun J, Bitler A, Skutelski E, Sela S. Role of M3 protein in the adherence and internalization of an invasive Streptococcus pyogenes strain by epithelial cells. FEMS Immunol Med Microbiol 2003; 38:205-213.
21. Fischetti VA. Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev 1989; 2:285-314.
22. Malone ML, Rozario N, Gavinski M, Goodwin J. The epidemiology of skin tears in the institutionalized elderly. J Am Geriatr Soc 1991; 39:591-595.
23. Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. MMWR Morb Mortal Wkly Rep 2002; 51(RR-16):1-44. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/ rr5116a1.htm. Accessed November 7, 2006.
24. Nicolle LE, Bentley DW, Garibaldi R, Neuhaus EF, Smith PW. Antimicrobial use in long-term-care facilities. The SHEA Long-Term-Care Committee. Infect Control Hosp Epidemiol 2000; 21:537-545.
25. Morita JY, Kahn E, Thompson T, et al. Impact of azithromycin on oropharyngeal carriage of group A streptococcus and nasopharyngeal carriage of macrolide-resistant Streptococcus pneumoniae. Pediatr Infect Dis J 2000; 19:41-46.
26. Public Health Agency of Canada. Guidelines for the prevention and control of invasive group A streptococcal disease. Can Commun Dis Rep 2006; 32(Suppl 2):1-26. Available at: http://www.phac-aspc.gc.ca/publicat/ccdr -rmtc/06vol32/32s2/index.html. Accessed November 7, 2006.
27. Smith A, Li A, Tolomeo O, Tyrrell GJ, Jamiesom F, Fisman D. Mass antibiotic treatment for group A streptococcus outbreaks in two long-term care facilities. Emerg Infect Dis 2003; 9:1260-1266.